|

Evaluating Disparities in Precision Oncology

RECRUITINGSponsored by Indiana University
Actively Recruiting
SponsorIndiana University
Started2024-01-26
Est. completion2028-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06081517

Summary

This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Ability to provide written informed consent and HIPAA authorization
2. Patients must be ≥ 18 years old at the time of consent
3. Patients planning to undergo molecular testing as part of their routine cancer care

Exclusion Criteria:

N/A

Conditions3

Advanced CancerCancerMetastatic Cancer

Locations1 site

Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202
Maria McQuade, BA(317) 278-5238mcquadem@iu.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.